Solstice Advanced Materials gets Barclays Overweight rating, $73 target
SOLS•Barclays initiated coverage of Solstice Advanced Materials with an Overweight rating and a $73 target price.
Related News
Zimmer Biomet and THINK Surgical extend exclusive TMINI distribution deal
ZBH•
Scinai expands CDMO business with $5.1 million development and clinical manufacturing agreement
SCNI•
Anchor Capital says US inflation rebound reflects supply shocks, not demand surge
TLT•
Albertsons Q2 adjusted EPS of $0.36 tops estimate of $0.33
ACI•
OMA taps EY as external auditor for fiscal 2026, replacing Deloitte
OMAB•